PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.250
+0.060 (5.04%)
Jun 29, 2026, 11:36 AM EDT - Market open
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $66.66 million as of June 29, 2026. Its market cap has increased by 17.72% in one year.
Market Cap
66.66M
Enterprise Value
-29.79M
1-Year Change
17.72%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $66.66M, a decrease of -95.87%. That is a compound annual growth rate of -42.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 66.66M | 0.23% |
| Dec 31, 2025 | 66.51M | -14.88% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeyondSpring | 69.49M |
| Seres Therapeutics | 68.56M |
| eXoZymes | 68.09M |
| ImageneBio | 67.90M |
| Cingulate | 66.81M |
| MediciNova | 64.97M |
| TScan Therapeutics | 63.31M |
| Veraxa Biotech AG | 58.50M |